144 related articles for article (PubMed ID: 15071192)
1. Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design.
Fedorov R; Vasan R; Ghosh DK; Schlichting I
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):5892-7. PubMed ID: 15071192
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the specificity of the nitric-oxide synthase inhibitors W1400 and Nomega-propyl-L-Arg for the inducible and neuronal isoforms.
Fedorov R; Hartmann E; Ghosh DK; Schlichting I
J Biol Chem; 2003 Nov; 278(46):45818-25. PubMed ID: 12954642
[TBL] [Abstract][Full Text] [Related]
3. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.
Li H; Raman CS; Martásek P; Masters BS; Poulos TL
Biochemistry; 2001 May; 40(18):5399-406. PubMed ID: 11331003
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors.
Matter H; Kotsonis P; Klingler O; Strobel H; Fröhlich LG; Frey A; Pfleiderer W; Schmidt HH
J Med Chem; 2002 Jul; 45(14):2923-41. PubMed ID: 12086480
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases.
Matter H; Kumar HS; Fedorov R; Frey A; Kotsonis P; Hartmann E; Fröhlich LG; Reif A; Pfleiderer W; Scheurer P; Ghosh DK; Schlichting I; Schmidt HH
J Med Chem; 2005 Jul; 48(15):4783-92. PubMed ID: 16033258
[TBL] [Abstract][Full Text] [Related]
6. Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound.
Flinspach M; Li H; Jamal J; Yang W; Huang H; Silverman RB; Poulos TL
Biochemistry; 2004 May; 43(18):5181-7. PubMed ID: 15122883
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for isoform-selective inhibition in nitric oxide synthase.
Poulos TL; Li H
Acc Chem Res; 2013 Feb; 46(2):390-8. PubMed ID: 23030042
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of bacterial nitric oxide synthase inhibitors.
Holden JK; Kang S; Hollingsworth SA; Li H; Lim N; Chen S; Huang H; Xue F; Tang W; Silverman RB; Poulos TL
J Med Chem; 2015 Jan; 58(2):994-1004. PubMed ID: 25522110
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
Flinspach ML; Li H; Jamal J; Yang W; Huang H; Hah JM; Gómez-Vidal JA; Litzinger EA; Silverman RB; Poulos TL
Nat Struct Mol Biol; 2004 Jan; 11(1):54-9. PubMed ID: 14718923
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of human nitric oxide synthase isoforms with the carbamidine moiety as a common structural element.
Moore WM; Webber RK; Fok KF; Jerome GM; Kornmeier CM; Tjoeng FS; Currie MG
Bioorg Med Chem; 1996 Sep; 4(9):1559-64. PubMed ID: 8894112
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic manipulation of nitric oxide signaling: targeting NOS dimerization and protein-protein interactions.
Paige JS; Jaffrey SR
Curr Top Med Chem; 2007; 7(1):97-114. PubMed ID: 17266598
[TBL] [Abstract][Full Text] [Related]
12. Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase.
Raman CS; Li H; Martásek P; Babu BR; Griffith OW; Masters BS; Poulos TL
J Biol Chem; 2001 Jul; 276(28):26486-91. PubMed ID: 11331290
[TBL] [Abstract][Full Text] [Related]
13. Structure-function studies on nitric oxide synthases.
Li H; Poulos TL
J Inorg Biochem; 2005 Jan; 99(1):293-305. PubMed ID: 15598508
[TBL] [Abstract][Full Text] [Related]
14. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES
J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor Bound Crystal Structures of Bacterial Nitric Oxide Synthase.
Holden JK; Dejam D; Lewis MC; Huang H; Kang S; Jing Q; Xue F; Silverman RB; Poulos TL
Biochemistry; 2015 Jul; 54(26):4075-82. PubMed ID: 26062720
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase and structure-based inhibitor design.
Poulos TL; Li H
Nitric Oxide; 2017 Feb; 63():68-77. PubMed ID: 27890696
[TBL] [Abstract][Full Text] [Related]
17. Photo-control of nitric oxide synthase activity using a caged isoform specific inhibitor.
Montgomery HJ; Perdicakis B; Fishlock D; Lajoie GA; Jervis E; Guy Guillemette J
Bioorg Med Chem; 2002 Jun; 10(6):1919-27. PubMed ID: 11937350
[TBL] [Abstract][Full Text] [Related]
18. Computational studies of competitive inhibitors of nitric oxide synthase (NOS) enzymes: towards the development of powerful and isoform-selective inhibitors.
Tafi A; Angeli L; Venturini G; Travagli M; Corelli F; Botta M
Curr Med Chem; 2006; 13(16):1929-46. PubMed ID: 16842203
[TBL] [Abstract][Full Text] [Related]
19. Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors.
Ji H; Li H; Flinspach M; Poulos TL; Silverman RB
J Med Chem; 2003 Dec; 46(26):5700-11. PubMed ID: 14667223
[TBL] [Abstract][Full Text] [Related]
20. Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.
Garcin ED; Arvai AS; Rosenfeld RJ; Kroeger MD; Crane BR; Andersson G; Andrews G; Hamley PJ; Mallinder PR; Nicholls DJ; St-Gallay SA; Tinker AC; Gensmantel NP; Mete A; Cheshire DR; Connolly S; Stuehr DJ; Aberg A; Wallace AV; Tainer JA; Getzoff ED
Nat Chem Biol; 2008 Nov; 4(11):700-7. PubMed ID: 18849972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
